Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.

Catherine Amlie-Lefond,Dennis W. W. Shaw,Andrew B. Cooper,Mark S. Wainwright,Adam Kirton,Ryan J. Felling,Michael G. Abraham,Mark T. Mackay,Michael M. Dowling,Marcela Torres,Michael J. Rivkin,Eric F. Grabowski,Sarah Lee,Jonathan E. Kurz,Hugh J. McMillan,Dwight Barry,Jacqueline Lee-Eng,Rebecca Ichord

Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.

2019

Catherine Amlie-Lefond
Dennis W. W. Shaw
Andrew B. Cooper
Mark S. Wainwright
Adam Kirton
Ryan J. Felling
Michael G. Abraham
Mark T. Mackay
Michael M. Dowling
Marcela Torres
Michael J. Rivkin
Eric F. Grabowski
Sarah Lee
Jonathan E. Kurz
Hugh J. McMillan
Dwight Barry
Jacqueline Lee-Eng
Rebecca Ichord

Background and Purpose— Data regarding the safety and efficacy of intravenous tPA (tissue-type plasminogen activator) in childhood acute arterial ischemic stroke are inadequate. The TIPS trial (Thr...

Keywords:

Physical therapy
Stroke
Medicine
Plasminogen activator
Arterial Ischemic Stroke
Cardiology
Tissue plasminogen activator
Internal medicine
Diabetes mellitus
acute stroke
tissue type

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations